| 000 | 01388 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515005808.0 | ||
| 264 | 0 | _c20060818 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2404033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYin, B | |
| 245 | 0 | 0 |
_aNfl gene inactivation in acute myeloid leukemia cells confers cytarabine resistance through MAPK and mTOR pathways. _h[electronic resource] |
| 260 |
_bLeukemia _cJan 2006 |
||
| 300 |
_a151-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCytarabine _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aNeurofibromin 1 _xdeficiency |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 700 | 1 | _aMorgan, K | |
| 700 | 1 | _aHasz, D E | |
| 700 | 1 | _aMao, Z | |
| 700 | 1 | _aLargaespada, D A | |
| 773 | 0 |
_tLeukemia _gvol. 20 _gno. 1 _gp. 151-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2404033 _zAvailable from publisher's website |
| 999 |
_c15930225 _d15930225 |
||